Navigation Links
New Parkinson's Drug Draws Mixed Reviews
Date:9/23/2009

ter effect on symptoms than the lower dose, so that masked our ability to detect its effect on disease progression," Olanow said. "We thought that this floor effect was why we couldn't see a difference."

Olanow was enthusiastic about the results. "This doesn't prove unequivocally that it [rasagiline] is neuroprotective, but there is no other rational explanation for the results," he said. "This is good news for Parkinson's patients."

Asked if he would prescribe the drug for that reason, Olanow said, "Yes, I would personally prescribe it."

A much more skeptical response came from Dr. William J. Weiner, chair of neurology at the University of Maryland, who took part in the study.

"The authors were very careful in the paper not to indicate that they had shown neuroprotection," Weiner said. "The tone of the article itself is moderate."

The methods used to determine trial results need scrutiny, he said. "They used a lot of very fancy mathematical models, some of which had not been used before," Weiner said. "Most neurologists wouldn't understand the mathematical models they used. Research neurologists don't deal with equations about the slope of curves."

And the end results were not impressive, he maintained. "The difference reported in the study is less than two points on a scale that has 150 points," Weiner said.

The reason why the lower dose worked, and the higher one didn't? "It simply could be luck," he said.

While rasagiline can provide benefits in reducing symptoms of early Parkinson's disease, Weiner said he was worried that "patients will be given what I believe to be false hopes" by the new study.

"It has mild symptomatic effects, but I do not prescribe this drug for neuroprotection and this study doesn't convince me to do that," Weiner said.

Several of the study authors have received consulting or lecturing fees from pharmaceutical companies, including Teva, the
'/>"/>

Copyright©2009 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Food Addicts Convention Draws 800 Members from 31 States, 5 Nations Around the World
2. Misuse of Pain Medication Draws Heightened Concerns
3. Tevas Forum Draws Key Pennsylvania Healthcare Leaders
4. Allscripts User Conference Draws 2,700, Sets Attendance Record
5. Boston Cardinal OMalley Withdraws Caritas Christi From Potential Abortion Scandal
6. Matrixx Initiatives Voluntarily Withdraws Zicam Cold Remedy Swabs, Zicam Cold Remedy Nasal Gel
7. Leading US Pediatric Hospital Draws First Dose with RIVA System
8. All Hands On Sweepstakes Thanks, Draws Industry to Web Site
9. Max Muscle Sports Nutrition Franchising Draws Record Interest
10. Schering-Plough Withdraws From Barclays Capital Global Healthcare Conference
11. Dr Timothy Huckabee Free Day of Dental Care Draws a Crowd
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New Parkinson's Drug Draws Mixed Reviews
(Date:12/19/2014)... Energy Textiles is excited to announce ... the world’s leading responsive textile, can now be ... are a number of benefits to wearing Celliant, ... balanced body temperature; which can lead to enhanced ... athletic performance; and overall wellness. In addition, the ...
(Date:12/19/2014)... Silver Dollar City is picking up new accolades ... time ever, Silver Dollar City has a title in the ... the park’s wood coaster Outlaw Run as the record holder ... week, Silver Dollar City is named in CNN Travel’s “Best ... 10Best awards for “Best Public Lights Display,” and is spotlighted ...
(Date:12/19/2014)... 19, 2014 Eufaula, Oklahoma, located just ... Eufaula, the state’s largest lake with more than 600 ... home to a little more than 3,000 residents, hosted ... Saturday, the 6th of December. , Featuring Santa, Christmas ... downtown Eufaula on Main Street. Narconon Arrowhead’s parade ...
(Date:12/19/2014)... An evening dress is perfect for any occasion ... a distinguished dresses retailer, has unveiled its new selection of ... this great shopping platform. Customers can view more ... Discount-Dress.com has been accepted and praised by customers for many ... stage for clients. In order to expand its market share, ...
(Date:12/19/2014)... The print component of Vision and ... of the Toronto Star, with a circulation of approximately ... digital component is distributed nationally through a vast social ... sites and partner outlets. To explore the digital version ... publication features an exclusive interview with Mark DeMontis ...
Breaking Medicine News(10 mins):Health News:Energy Textiles Launches Celliant Revitalizing Bedsheets 2Health News:Silver Dollar City Nets New Titles: Guinness Book of World Records, Plus CNN Travel, USA Today & Fodor’s Top Places for Christmas Lights 2Health News:Narconon Arrowhead Debuts Float at Checotah and Eufaula Christmas Parades 2Health News:Narconon Arrowhead Debuts Float at Checotah and Eufaula Christmas Parades 3Health News:Attractive Evening Dresses Announced by Discount-Dress.com 2Health News:Mark DeMontis, Founder of Courage Canada, shares his passion for bringing hockey to those affected by blindness in Mediaplanet’s “Vision and Hearing” campaign 2
... Minn., June 24 Here are,highlights from the ... may cite,this publication as often as you wish. ... Letter attribution is required. Include the following,subscription information ... or call toll-free for subscription,information, 800-333-9037, extension 9PR1., ...
... provider of health and,human services for government clients, ... Iowa Department of Human Services (DHS) to perform,administrative ... Iowa (hawk-i),Program. As part of Iowa,s State Children,s ... insurance coverage for,uninsured children in Iowa whose families ...
... Available for all U.S. Counties, ATLANTA, June 24 ... United States, an increase of more than 3 million,in ... estimates,released today by the Centers for Disease Control and ... U.S. population has diabetes., In addition to the ...
... New Orleans, LA Eugene A. Woltering, MD, FACS, The ... Sections of Surgical Oncology & Endocrine Surgery at LSU Health ... for a one-step method to rapidly identify "sentinel nodes;" the ... primary cancer. Preliminary research indicates that the procedure which consists ...
... & Injury Prevention Information and Medicare Part ... ... 24 WellPoint, Inc. today announced,that it has received ... Resource Center. NuestroBien.com ( http://www.nuestrobien.com ),was the company,s most ...
... Americans are experiencing,rising prices on many essentials, ... represent one of the fastest-growing medical,expenses. From 1990 ... billion to $200.7 billion, according to a recent ... help, Giant is introducing a new way for ...
Cached Medicine News:Health News:June 2008 Mayo Clinic Health Letter Highlights New MRI Scanning Technology, Obesity-Related Cancer, and Do-It-Yourself Massage 2Health News:June 2008 Mayo Clinic Health Letter Highlights New MRI Scanning Technology, Obesity-Related Cancer, and Do-It-Yourself Massage 3Health News:June 2008 Mayo Clinic Health Letter Highlights New MRI Scanning Technology, Obesity-Related Cancer, and Do-It-Yourself Massage 4Health News:Iowa Awards Policy Studies Inc. (PSI) Contract to Operate Its hawk-i Children's Health Insurance Program 2Health News:Number of People With Diabetes Increases to 24 Million 2Health News:Number of People With Diabetes Increases to 24 Million 3Health News:LSUHSC inventor awarded patent for new procedure to detect cancer spread 2Health News:LSUHSC inventor awarded patent for new procedure to detect cancer spread 3Health News:WellPoint Web Sites Receive Six World Wide Web Health Awards 2Health News:New Giant Pharmacy Program Offers Relief for Your Family and Your Wallet 2
(Date:12/19/2014)... 18, 2014 Capnia, Inc. (NASDAQ: ... medical diagnostics based on its proprietary Sensalyze™ Technology ... announced financial results for the third quarter and ... "Following the completion of our initial public offering ... the recently initiated CoSense® commercial launch," said Anish ...
(Date:12/19/2014)... LYON, France , Dec. 19, 2014 /PRNewswire/ ... and Adocia (Euronext Paris: FR0011184241 – ADOC) today announced ... insulin, known as BioChaperone Lispro, for treatment in people ... relies on Adocia,s proprietary BioChaperone® technology and is currently ... will develop BioChaperone Lispro with the goal of optimizing ...
(Date:12/17/2014)... Dec. 17, 2014  Strategic Health Services, Inc. (SHS), ... today announced a strategic agreement with QualCare, Inc., a leading ... Jersey regional marketplace.  This agreement will further ... and wellness solutions QualCare brings to its clients in ... region. QualCare plans cover more than ...
Breaking Medicine Technology:Capnia Reports Third Quarter 2014 Financial Results 2Capnia Reports Third Quarter 2014 Financial Results 3Capnia Reports Third Quarter 2014 Financial Results 4Capnia Reports Third Quarter 2014 Financial Results 5Capnia Reports Third Quarter 2014 Financial Results 6Capnia Reports Third Quarter 2014 Financial Results 7Capnia Reports Third Quarter 2014 Financial Results 8Lilly and Adocia Announce Alliance to Co-Develop Ultra-Rapid Insulin Based on BioChaperone Technology 2Lilly and Adocia Announce Alliance to Co-Develop Ultra-Rapid Insulin Based on BioChaperone Technology 3Strategic Health Services to collaborate with QualCare on Population Health and Wellness Technology for QualCare Members 2Strategic Health Services to collaborate with QualCare on Population Health and Wellness Technology for QualCare Members 3
... Today is an exciting day for men with advanced prostate ... affected. Today a new prostate cancer treatment option, Provenge, was approved by ... , , ... innovative treatment option made available for patients with asymptomatic or minimally symptomatic ...
... Dendreon Corporation (Nasdaq: DNDN ) ... Administration (FDA) has approved PROVENGE® (sipuleucel-T), an autologous ... minimally symptomatic metastatic, castrate-resistant (hormone-refractory) prostate cancer (CRPC). ... against prostatic acid phosphatase (PAP), an antigen expressed ...
Cached Medicine Technology:Advanced Prostate Cancer Patients Finally Have Another Option 2FDA Approves PROVENGE(R) for the Treatment of Men with Advanced Prostate Cancer 2FDA Approves PROVENGE(R) for the Treatment of Men with Advanced Prostate Cancer 3FDA Approves PROVENGE(R) for the Treatment of Men with Advanced Prostate Cancer 4FDA Approves PROVENGE(R) for the Treatment of Men with Advanced Prostate Cancer 5FDA Approves PROVENGE(R) for the Treatment of Men with Advanced Prostate Cancer 6FDA Approves PROVENGE(R) for the Treatment of Men with Advanced Prostate Cancer 7
... a mesh plug to treat large or ... hernias and femoralhernias. The self-expanding plug perfectly ... completely. Premilene Mesh Self-Forming Plug is a ... Mesh. The plug corresponds with all properties ...
... Lightweight and ergonomically designed with a 10-foot, ... Megadyne's E-Z PEN reusable electrosurgical pencils are ... the patented E-Z CLEAN non-stick tips allowing ... faster. The E-Z CLEAN PTFE coating ...
... Applied Fiberoptics Gemini surgical headlight is perfectly ... is durable and ultra-low-profile and illuminates brilliantly ... the annoying "rams effect." The fully adjustable ... designed to sit low on the brow, ...
... ... , ... MC-3 with Multiport - A three-lamp lightsource , it ... reserved for backup. Designed with managed care in mind, it includes universal turrets to accept most ...
Medicine Products: